Global Clinical Immunoassay Analyzer Market Research Report 2022

Immunoassay analyzers perform biochemical tests to detect antibodies that are specific proteins produced by the body to fight antigens. In clinical laboratories, these analyzers are used to detect a variety of substances, including infectious diseases, cardiac markers, endocrine hormone testing, proteins, and for viral or bacterial determination, from a patient’s biological sample such as blood or body fluid. 
Due to the COVID-19 pandemic, the global Clinical Immunoassay Analyzer market size is estimated to be worth US$ 4713.1 million in 2021 and is forecast to a readjusted size of US$ 6935.9 million by 2028 with a CAGR of 5.6% during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Clinical Immunoassay Analyzer market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Clinical Immunoassay Analyzer landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
According to the report, a key driver of market growth is the rising demand for next-generation immunodiagnostics. Next-generation immunodiagnostic equipment are being designed to address the needs of modern clinical laboratories. These instruments provide high-quality, reliable test results for patients and clinicians. Manufacturers enhance the hardware by innovating technology to improve workflow and turnaround time. 
This report focuses on Clinical Immunoassay Analyzer volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Clinical Immunoassay Analyzer market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Global Clinical Immunoassay Analyzer Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Instruments
Services and Spare
Segment by Application
Hospital
Clinic
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Abbott Diagnostics
Beckman Coulter
bioMérieux
Roche Diagnostics
Siemens Healthcare Diagnostics
Affimetrix
Boditech Med
DiaSorin
DRG International
Enzo Life Sciences
EMD Millipore
Immunodiagnostics System
Inova Diagnostics
Meso Scale Discovery
Nova Century Scientific
Olympus
Quidel
Radiometer
Randox Laboratories
SDIX
Tecan
Thermo Fisher Scientific